The Antitumor Activity of Combinations of Cytotoxic Chemotherapy and Immune Checkpoint Inhibitors Is Model-Dependent

In spite of impressive response rates in multiple cancer types, immune checkpoint inhibitors (ICIs) are active in only a minority of patients. Alternative strategies currently aim to combine immunotherapies with conventional agents such as cytotoxic chemotherapies. Here, we performed a study of PD-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Grasselly, Chloé, Denis, Morgane, Bourguignon, Aurore, Talhi, Nolan, Mathe, Doriane, Tourette, Anne, Serre, Laurent, Jordheim, Lars Petter, Matera, Eva Laure, Dumontet, Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6190749/
https://www.ncbi.nlm.nih.gov/pubmed/30356816
http://dx.doi.org/10.3389/fimmu.2018.02100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6190749/
https://www.ncbi.nlm.nih.gov/pubmed/30356816
http://dx.doi.org/10.3389/fimmu.2018.02100

Ejemplares similares